The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Open accessAbstract
Glioma stem cells (GSCs) constitute a slow-dividing, small population within a heterogeneous glioblastoma. They are able to self-renew, recapitulate a whole tumor, and differentiate into other specific glioblastoma multiforme (GBM) subpopulations. Therefore, they have been held responsible for malignant relapse after primary standard therapy and the poor prognosis of recurrent GBM. The failure of current therapies to eliminate specific GSC subpopulations has been considered a major factor contributing to the inevitable recurrence in GBM patients after treatment. Here, we discuss the molecular mechanisms of chemoresistance of GSCs and the reasons why complete eradication of GSCs is so difficult to achieve. We will also describe the targeted therapies currently available for GSCs and possible mechanisms to overcome such chemoresistance and avoid therapeutic relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression
Wei, J., Barr, J., Kong, L.-Y., Wang, Y., Wu, A., Sharma, A. K., Gumin, J., Henry, V., Colman, H., Sawaya, R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1983 · Cited by 221
RetractedRadiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Identification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., & Brenner, M. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400067101 · Cited by 1,280
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,050
Vescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
Silber, J., Lim, D. A., Petritsch, C., Persson, A. I., Maunakea, A. K., Yu, M., Vandenberg, S. R., Ginzinger, D. G., James, C. D., Costello, J. F., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-14 · Cited by 957
Stupp, R., Dietrich, P.-Y., Ostermann, S., Pica, A., Maillard, I. P., Maeder, P., Meuli, R. A., Janzer, R. C., Pizzolato, G., Miralbell, R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1375 · Cited by 856
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Zhou, B.-B. S., Zhang, H., Damelin, M., Geles, K. G., Grindley, J. C., & Dirks, P. B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2137 · Cited by 841
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813 · cited 1×
“Much prior work has focused on targeting HIFs and their downstream effectors to disrupt GSC signaling and survival [88,89].”
Bleau, A.-M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., & Holland, E. C. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.007 · Cited by 808
Isolation of cancer stem cells from adult glioblastoma multiforme
Yuan, X., Curtin, J., Xiong, Y., Liu, G., Waschsmann-Hogiu, S., Farkas, D. L., Black, K. L., & Yu, J. S. (2004) · Oncogene · doi:10.1038/sj.onc.1208311 · Cited by 798
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Snuderl, M., Fazlollahi, L., Le, L. P., Nitta, M., Zhelyazkova, B. H., Davidson, C. J., Akhavanfard, S., Cahill, D. P., Aldape, K. D., Betensky, R. A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.005 · Cited by 707
Alcantara Llaguno, S., Chen, J., Kwon, C.-H., Jackson, E. L., Li, Y., Burns, D. K., Alvarez-Buylla, A., & Parada, L. F. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.006 · Cited by 694
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Notch Promotes Radioresistance of Glioma Stem Cells
Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X.-F., White, R. R., Rich, J. N., & Sullenger, B. A. (2010) · Stem Cells · doi:10.1002/stem.261 · Cited by 656
Mao, P., Joshi, K., Li, J., Kim, S.-H., Li, P., Santana-Santos, L., Luthra, S., Chandran, U. R., Benos, P. V., Smith, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221478110 · Cited by 642
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Bøe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23130 · Cited by 567
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S. M., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling
Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000121 · Cited by 523
Ostermann, S., Csajka, C., Buclin, T., Leyvraz, S., Lejeune, F., Decosterd, L. A., & Stupp, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0807 · Cited by 518
Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality
Legler, J. M., Ries, L. A. G., Smith, M. A., Warren, J. L., Heineman, E. F., Kaplan, R. S., & Linet, M. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.16.1382 · Cited by 452
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
Seidel, S., Garvalov, B. K., Wirta, V., von Stechow, L., Schänzer, A., Meletis, K., Wolter, M., Sommerlad, D., Henze, A.-T., Nistér, M., et al. (2010) · Brain · doi:10.1093/brain/awq042 · Cited by 440
Acidic stress promotes a glioma stem cell phenotype
Hjelmeland, A. B., Wu, Q., Heddleston, J. M., Choudhary, G. S., MacSwords, J., Lathia, J. D., McLendon, R., Lindner, D., Sloan, A., & Rich, J. N. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.150 · Cited by 402
Yip, S., Miao, J., Cahill, D. P., Iafrate, A. J., Aldape, K., Nutt, C. L., & Louis, D. N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3012 · Cited by 400
Zhu, T. S., Costello, M. A., Talsma, C. E., Flack, C. G., Crowley, J. G., Hamm, L. L., He, X., Hervey-Jumper, S. L., Heth, J. A., Muraszko, K. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4269 · Cited by 400
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing
Campbell, P. J., Pleasance, E. D., Stephens, P. J., Dicks, E., Rance, R., Goodhead, I., Follows, G. A., Green, A. R., Futreal, P. A., & Stratton, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801523105 · Cited by 365
The Implications of Clonal Genome Evolution for Cancer Medicine
Aparicio, S., & Caldas, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204892 · Cited by 356
Auffinger, B., Tobias, A. L., Han, Y., Lee, G., Guo, D., Dey, M., Lesniak, M. S., & Ahmed, A. U. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.31 · Cited by 349
Self-citationIntratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Pistollato, F., Abbadi, S., Rampazzo, E., Persano, L., Della Puppa, A., Frasson, C., Sarto, E., Scienza, R., D'avella, D., & Basso, G. (2010) · Stem Cells · doi:10.1002/stem.415 · Cited by 322
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Beier, D., Schulz, J. B., & Beier, C. P. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-128 · Cited by 312
Hermisson, M., Klumpp, A., Wick, W., Wischhusen, J., Nagel, G., Roos, W., Kaina, B., & Weller, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03583.x · Cited by 311
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
Beier, D., Röhrl, S., Pillai, D. R., Schwarz, S., Kunz-Schughart, L. A., Leukel, P., Proescholdt, M., Brawanski, A., Bogdahn, U., Trampe-Kieslich, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6878 · Cited by 294
Smith, L. M., Nesterova, A., Ryan, M. C., Duniho, S., Jonas, M., Anderson, M., Zabinski, R. F., Sutherland, M. K., Gerber, H.-P., Van Orden, K. L., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604437 · Cited by 286
Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas.
Shapiro, J. R., Yung, W. K. A., & Shapiro, W. R. (1981) · PubMed · Cited by 285
Rheinbay, E., Suvà, M. L., Gillespie, S. M., Wakimoto, H., Patel, A. P., Shahid, M., Oksuz, O., Rabkin, S. D., Martuza, R. L., Rivera, M. N., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.021 · Cited by 276
Portnow, J., Badie, B., Chen, M., Liu, A., Blanchard, S., & Synold, T. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1349 · Cited by 255
Drug Resistance in Glioblastoma: A Mini Review
Haar, C. P., Hebbar, P., Wallace, G. C., Das, A., Vandergrift, W. A., Smith, J. A., Giglio, P., Patel, S. J., Ray, S. K., & Banik, N. L. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0701-1 · Cited by 254
Facchino, S., Abdouh, M., Chatoo, W., & Bernier, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1634-10.2010 · Cited by 253
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
Huang, Z., Cheng, L., Guryanova, O. A., Wu, Q., & Bao, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0078-y · Cited by 248
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells
Gal, H., Pandi, G., Kanner, A. A., Ram, Z., Lithwick-Yanai, G., Amariglio, N., Rechavi, G., & Givol, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.107 · Cited by 234
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Wei, J., Wu, A., Kong, L.-Y., Wang, Y., Fuller, G., Fokt, I., Melillo, G., Priebe, W., & Heimberger, A. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016195 · Cited by 220
Brada, M., Judson, I., Beale, P., Moore, S., Reidenberg, P., Statkevich, P., Dugan, M., Batra, V, & Cutler, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690802 · Cited by 208
Ulasov, I. V., Nandi, S., Dey, M., Sonabend, A. M., & Lesniak, M. S. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00062 · Cited by 204
Self-citationElevated invasive potential of glioblastoma stem cells
Cheng, L., Wu, Q., Guryanova, O. A., Huang, Z., Huang, Q., Rich, J. N., & Bao, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.123 · Cited by 199
Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
Ropolo, M., Daga, A., Griffero, F., Foresta, M., Casartelli, G., Zunino, A., Poggi, A., Cappelli, E., Zona, G., Spaziante, R., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0409 · Cited by 198
Wang, C.-H., Chiou, S.-H., Chou, C.-P., Chen, Y.-C., Huang, Y.-J., & Peng, C.-A. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.06.010 · Cited by 194
Dahan, P., Martinez Gala, J., Delmas, C., Monferran, S., Malric, L., Zentkowski, D., Lubrano, V, Toulas, C., Cohen-Jonathan Moyal, E., & Lemarie, A. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.509 · Cited by 187
Bartkova, J., Hamerlik, P., Stockhausen, M.-T., Ehrmann, J., Hlobilkova, A., Laursen, H., Kalita, O., Kolar, Z., Poulsen, H. S., Broholm, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.249 · Cited by 171
Laminin alpha 2 enables glioblastoma stem cell growth
Lathia, J. D., Li, M., Hall, P. E., Gallagher, J., Hale, J. S., Wu, Q., Venere, M., Levy, E., Rani, M. R. S., Huang, P., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23674 · Cited by 169
The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
Filatova, A., Acker, T., & Garvalov, B. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.008 · Cited by 167
Biology of Glioma Cancer Stem Cells
Park, D. M., & Rich, J. N. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0111-2 · Cited by 161
Rosso, L., Brock, C. S., Gallo, J. M., Saleem, A., Price, P. M., Turkheimer, F. E., & Aboagye, E. O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2356 · Cited by 159
Ernst, A., Campos, B., Meier, J., Devens, F., Liesenberg, F., Wolter, M., Reifenberger, G., Herold-Mende, C., Lichter, P., & Radlwimmer, B. (2010) · Oncogene · doi:10.1038/onc.2010.83 · Cited by 147
Residual tumor cells are unique cellular targets in glioblastoma
Glas, M., Rath, B. H., Simon, M., Reinartz, R., Schramme, A., Trageser, D., Eisenreich, R., Leinhaas, A., Keller, M., Schildhaus, H., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22036 · Cited by 143
DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?
Johannessen, T.-C. A., Bjerkvig, R., & Tysnes, B. B. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.125 · Cited by 141
Galán‐Moya, E. M., Guelte, A. L., Lima‐Fernandes, E., Thirant, C., Dwyer, J., Bidère, N., Couraud, P., Scott, M. G. H., Junier, M., Chneiweiss, H., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.39 · Cited by 137
Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas.
Bobola, M. S., Blank, A., Berger, M. S., Stevens, B. A., & Silber, J. R. (2001) · PubMed · Cited by 134
Martín, V., Sánchez‐Sánchez, A. M., Herrera, F., Gomez‐Manzano, C., Fueyo-Margareto, J., Vega, M. A. Á., Antolín, I., & Rodríguez, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.188 · Cited by 133
Chang, C.-J., Hsu, C.-C., Yung, M.-C., Chen, K., Tzao, C., Wu, W., Chou, H., Lee, Y., Lu, K., Chiou, S., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.040 · Cited by 130
Little, S. E., Popov, S., Jury, A., Bax, D. A., Doey, L. J., Al‐Sarraj, S., Jürgensmeier, J. M., & Jones, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4069 · Cited by 123
Notching on Cancer’s Door: Notch Signaling in Brain Tumors
Teodorczyk, M., & Schmidt, M. H. H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00341 · Cited by 116
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15
Mao, X., Zhang, X., Xue, X., Guo, G., Wang, P., Zhang, W., Fei, Z., Zhen, H., You, S., & Yang, H. (2009) · Translational Oncology · doi:10.1593/tlo.09136 · Cited by 113
Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies
Ahmed, A. U., Auffinger, B., & Lesniak, M. S. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.42 · Cited by 103
Self-citationSide population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
Golebiewska, A., Bougnaud, S., Stieber, D., Brons, N. H. C., Vallar, L., Hertel, F., Klink, B., Schröck, E., Bjerkvig, R., & Niclou, S. P. (2013) · Brain · doi:10.1093/brain/awt025 · Cited by 95
Li, W., Li, Y., Tao, B., Yi-cheng, L., Hu, G., Liu, H., He, J., Xu, Y., & Yu, H.-Y. (2010) · PubMed · Cited by 86
Signore, M., Pelacchi, F., Martino, S. D., Runci, D., Biffoni, M., Giannetti, S., Morgante, L., de Majo, M., Petricoin, E., Stancato, L. F., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.188 · Cited by 85
Vecchio, D., Daga, A., Carra, E., Marubbi, D., Baio, G., Neumaier, C. E., Vagge, S., Corvò, R., Brisigotti, M. P., Ravetti, J. L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28680 · Cited by 80
Sensitivity to temozolomide in brain tumor initiating cells
Blough, M. D., Westgate, M. R., Beauchamp, D., Kelly, J. J., Stechishin, O. D. M., Ramirez, A. L., Weiss, S., & Cairncross, J. G. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq032 · Cited by 77
Gli1 is a potential target for alleviating multidrug resistance of gliomas
Cui, D., Xu, Q., Wang, K., & Che, X. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.006 · Cited by 75
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures
Carra, E., Barbieri, F., Marubbi, D., Pattarozzi, A., Favoni, R. E., Florio, T., & Daga, A. (2013) · Cell Cycle · doi:10.4161/cc.23372 · Cited by 75
ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells
Nadkarni, A., Shrivastav, M., Mladek, A. C., Schwingler, P. M., Grogan, P. T., Chen, J., & Sarkaria, J. N. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0979-0 · Cited by 70
Xu, Z., Wang, K., Li, X., Chen, S., Deng, J., Cheng, Y. Z., & Wang, Z. (2012) · Ultrasonics · doi:10.1016/j.ultras.2012.06.005 · Cited by 68
Glioblastoma Cancer Stem-Like Cells: Implications for Pathogenesis and Treatment
Nduom, E. K.-E., Hadjipanayis, C. G., & Meir, E. G. V. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182452e0d · Cited by 65
Chemoresistance and Chemotherapy Targeting Stem-Like Cells in Malignant Glioma
Sørensen, M. D., Fosmark, D. S., Hellwege, S., Beier, D., Kristensen, B. W., & Beier, C. P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16537-0_7 · Cited by 58
Adoptive Cell Therapies for Glioblastoma
Bielamowicz, K., Khawja, S. N., & Ahmed, N. M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00275 · Cited by 56
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.
Aldea, M. D., Petrushev, B., Şoriţău, O., Tomuleasa, C., Berindan‐Neagoe, I., Filip, G. A., Cherecheș, G., Cenariu, M., Craciun, L., Tatomir, C. B., et al. (2014) · PubMed · Cited by 51
Imai, Y., Yoshimori, M., Fukuda, K., Yamagishi, H., & Ueda, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1724 · Cited by 45
Cancer stem cells: the development of new cancer therapeutics
Scatena, R., Bottoni, P., Pontoglio, A., & Giardina, B. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.573780 · Cited by 44
Fei, S., Xing, Q., Kedong, S., Guangchun, J., Liu, J., & Wei, Q. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1104-z · Cited by 43
Wu, J., Lai, G., Wan, F., Xiao, Z., Zeng, L., Wang, X., Ye, F., & Lei, T. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.226.267 · Cited by 42
Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells
Gong, W., Wang, Z., Wan, Y., Shi, L., & Zhou, Y. (2014) · Neuroreport · doi:10.1097/wnr.0000000000000161 · Cited by 42
Kanno, H., Sato, H., Yokoyama, T., Yoshizumi, T., & Yamada, S. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1773 · Cited by 37
Wharton, S. B., McNelis, U., Bell, H. S., & Whittle, I. R. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2000.00288.x · Cited by 32
Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma
Wu, Z. B., Qiu, C., Zhang, A., Cai, L., Lin, S., Yao, Y., Tang, Q. S., Xu, M., Hua, W., Chu, Y. W., et al. (2014) · Journal of Immunology Research · doi:10.1155/2014/131494 · Cited by 31
Gillespie, D. L., Aguirre, M. T., Ravichandran, S., Leishman, L. L., Berrondo, C., Gamboa, J. T., Wang, L., King, R., Wang, X., Tan, M., et al. (2014) · Journal of neurosurgery · doi:10.3171/2014.10.jns132363 · Cited by 27
(2003) · PubMed
Cited by
Wnt/β-catenin-driven EMT regulation in human cancers
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321
WNT signaling in glioblastoma and therapeutic opportunities
Lee, Y., Lee, J.-K., Ahn, S. H., Lee, J., & Nam, D.-H. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.140 · Cited by 273
Glioblastoma Microenvironment and Cellular Interactions
Crivii, C.-B., Boșca, A. B., Melincovici, C. S., Constantin, A.-M., Mărginean, M., Dronca, E., Suflețel, R., Gonciar, D., Bungărdean, M., & Șovrea, A. (2022) · Cancers · doi:10.3390/cancers14041092 · Cited by 81
Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma
Rasmussen, R. D., Gajjar, M. K., Jensen, K. E., & Hamerlik, P. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.014 · Cited by 79
Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells
Was, H., Krol, S. K., Rotili, D., Mai, A., Wojtas, B., Kaminska, B., & Maleszewska, M. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0598-5 · Cited by 78
Metadata
- Authors
- Auffinger, B., Spencer, D., Pytel, P., Ahmed, A. U., & Lesniak, M. S.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2015-05-31
- Volume
- 15
- Issue
- 7
- Pages
- 741-752
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2101093124
- Cited by
- 292
- References
- 107
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.